Skip to main content
Skip to section navigation
Skip to footer
Search
MENU
CLOSE
About Us
Overview
Board
Management Team
Corporate Directory
Our Science
Gene Silencing
Intellectual Property
Partnering
Our Programs
Areas of Research
Pipeline
Presentations and Publications
For Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Contact Us
Search
IR Calendar
For Investors
For Investors
Overview
News & Events
Press Releases
IR Calendar
Media Coverage
Email Alerts
Company Info
Company Profile
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
ASX Annual Reports
Form 8937 - Reverse Stock Split
Stock Data
Quote and Chart
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
At-a-Glance
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Interim BB-301 Phase 1b/2a Clinical Study Update
Nov 3, 2025 8:00 am EST
Webcast
Audio
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed